NCT07806682

Brief Summary

To conduct a randomized controlled trial (RCT) targeting lung cancer patients with cancer-related fatigue to achieve the following objectives: Objective 1: To investigate whether a low-intensity endurance exercise intervention can effectively improve mitochondrial DNA content, mitochondrial function, mitochondrial oxidative phosphorylation complex enzyme concentrations, cellular bioelectrical impedance phase angle, cancer-related fatigue, and quality of life in lung cancer patients with cancer-related fatigue. Objective 2: To explore whether the low-intensity endurance exercise intervention improves cancer-related fatigue and quality of life in lung cancer patients through direct or indirect effects by modulating mitochondrial DNA content, mitochondrial function, mitochondrial oxidative phosphorylation complex enzyme concentrations, and cellular bioelectrical impedance phase angle.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
10mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Mar 2025Jul 2027

Study Start

First participant enrolled

March 10, 2025

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

August 26, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 8, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

September 8, 2026

Status Verified

August 1, 2026

Enrollment Period

2.4 years

First QC Date

August 26, 2026

Last Update Submit

September 4, 2026

Conditions

Keywords

Cancer-Related FatigueEndurance ExerciseMitochondrial FunctionBioelectrical Impedance Phase AngleQuality of LifeLung Cancer

Outcome Measures

Primary Outcomes (4)

  • Change from baseline in Cancer-Related Fatigue (CRF)

    Evaluated by the Brief Fatigue Inventory-Taiwan (BFI-T). The total score ranges from 0 to 90, with higher scores indicating greater fatigue severity and interference with daily life. Higher scores indicate greater fatigue severity.

    Baseline, Week 6, and Week 12

  • Change from baseline in mitochondrial oxidative phosphorylation complex enzyme concentrations

    Concentrations of mitochondrial complex enzymes (Complex I-V) determined via ELISA at an absorbance wavelength of 600 nm. Expressed in ng/mL

    Baseline, Week 6, and Week 12

  • Change from baseline in Quality of Life (QoL)

    Evaluated using the Functional Assessment of Cancer Therapy-General; FACT-G. The scale comprises four subscales: (1) Physical Well-Being (PWB): 7 items, score range 0-28; (2) Social/Family Well-Being (SWB): 7 items, score range 0-28; (3) Emotional Well-Being (EWB): 6 items, score range 0-24; and (4) Functional Well-Being (FWB): 7 items, score range 0-28. Higher scores indicate better quality of life

    Baseline, Week 6, and Week 12

  • Change from baseline in phase angle and skeletal muscle mass

    Measured using the InBody S10 bioelectrical impedance analyzer. Phase angle is expressed in degrees (°), and skeletal muscle mass is expressed in kilograms (kg).

    Baseline, Week 6, and Week 12

Study Arms (3)

Control Group

NO INTERVENTION

No exercise intervention will be implemented, and participants will carry out their daily activities according to their previous lifestyle habits.

Continuous Training Group

EXPERIMENTAL

Level 2 low-intensity continuous endurance exercise: Participants will perform Level 2 low-intensity endurance exercise training continuously for at least 30 minutes per day, at least 5 days per week, for 12 consecutive weeks. The exercise intensity will be 75-80% of peak heart rate, with a rating of perceived exertion of 11-12. At this intensity, participants will perceive the exercise as easy, but their breathing sound will increase; they will be able to converse comfortably during exercise but may occasionally need to pause for breath

Behavioral: Low-Intensity Endurance Continuous Exercise

Intermittent Training Group

EXPERIMENTAL

Participants will perform alternating training consisting of 3 minutes of Level 2 low-intensity endurance exercise and 3 minutes of Level 1 minimal-intensity endurance exercise, for a total of 5 alternating cycles. The training will be performed continuously for at least 30 minutes per day, at least 5 days per week, for 12 consecutive weeks. Level 1 exercise intensity will be 65-75% of peak heart rate, with a rating of perceived exertion below 11, indicating that participants perceive the exercise as very easy.

Behavioral: Low-Intensity Endurance Interval Exercise

Interventions

Participants perform alternating low-intensity endurance training consisting of 3-minute Level 2 exercise and 3-minute Level 1 exercise for 30 minutes per day, 5 days per week, for 12 weeks.

Intermittent Training Group

Participants perform continuous low-intensity endurance exercise for 30 minutes per day, 5 days per week, for 12 weeks at 75%-80% peak heart rate and RPE 11-12.

Continuous Training Group

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are diagnosed with lung cancer by a physician ;
  • Patients aged 20-70 years;
  • Patients who are determined by a physician, after assessment of their physical condition, to be suitable for exercise;
  • Patients who have graduated from elementary school or above.

You may not qualify if:

  • Patients who are unable to communicate in Mandarin, Taiwanese, or Hakka;
  • Patients who are determined by a physician to be physically unsuitable for performing any exercise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Lung NeoplasmsDisease

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Hsiu Ting Tsai, PhD

CONTACT

Hsin-Hui Huang, Master's degree

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A randomized controlled trial with 3 parallel groups: (1) Control group: maintaining usual lifestyle; (2) Continuous training group: low-intensity endurance continuous exercise for 30 mins, 5 days/week for 12 weeks; (3) Intermittent training group: low-intensity endurance intermittent exercise (alternating level 2 and level 1 intensity) for 30 mins, 5 days/week for 12 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2026

First Posted

September 8, 2026

Study Start

March 10, 2025

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

September 8, 2026

Record last verified: 2026-08

Locations